MarkRNeustromDOFAAAAI, FACAAI

Allergy & Immunology • Overland Park, KS

Physician at Kansas City Allergy and Asthma Associates

Join to view full profile

Dr. Neustrom is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Neustrom's full profile

Already have an account?

Office
8675 College Blvd
Suite 200
Overland Park, KS 66210
Phone+1 913-491-5501

Summary

I am a board-certified allergist with Kansas City Allergy and Asthma Associates with special areas of interest in hereditary angioedema, eosinophilic esophagitis and primary immune deficiency.

Education & Training

Medical College of Wisconsin Affiliated HospitalsFellowship, Allergy and Immunology, 1992 - 1994
University of South DakotaResidency, Internal Medicine, 1987 - 1990
Des Moines University College of Osteopathic MedicineClass of 1987
Iowa State UniversityBS, Zoology, 1975 - 1979

Certifications & Licensure

KS State License 1994 - 2025
MO State License 1994 - 2023
IA State License 1988 - 1995
WI State License 1992 - 1995
IL State License 1988 - 1991
American Board of Allergy and Immunology Allergy & Immunology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly
Fellow American College of Asthma, Allergy and Immunology, 1999
Super Doctor SuperDoctors.com
Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Join now to see all

Clinical Trials

Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema Start of enrollment: 2010 Feb 01
Completed
A Study to Evaluate the Efficacy, Response Duration and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1) Start of enrollment: 2011 Mar 01
Completed
Phase 3
A Long Term Safety Study of BCX7353 in Hereditary Angioedema Start of enrollment: 2018 Feb 16
Completed
Phase 2, Phase 3

Publications & Presentations

PubMed

84 citations
Clinical efficacy and pharmacokinetics of montelukast in dyspeptic children with duodenal eosinophilia.
Craig A. Friesen, Gregory L. Kearns, Linda Andre, Mark R. Neustrom, Charles C. Roberts
Journal of Pediatric Gastroenterology and Nutrition. 2004-03-01
87 citations
Treatment of eosinophilic gastroenteritis with montelukast.
Mark R. Neustrom, Craig A. Friesen
The Journal of Allergy and Clinical Immunology. 1999-08-01

Journal Articles

T cell responses in a patient with the hyper-IgE syndrome treated with interferon.
Neustrom MR, Murali PS, Kelly KJ, Zvulunov A, Estherly NB, J Allergy Clin Immunol 93:205
Seasonal asthma: diagnosis and treatment.
Neustrom, MR, JAOA 1997; 97(6):S10-S14

Professional Memberships

External Links

KCAA web pagehttp://www.kcallergy.com